Testosterone Enanthate Patent Expiration
Testosterone Enanthate is Used for testosterone replacement therapy in individuals with low testosterone levels. It was first introduced by Endo Pharmaceuticals Inc
Testosterone Enanthate Patents
Given below is the list of patents protecting Testosterone Enanthate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Xyosted (autoinjector) | US10646495 | Testosterone ester triglyceride formulations | Aug 30, 2038 | Antares Pharma Inc |
Xyosted (autoinjector) | US9950125 | Needle assisted jet injection administration of testosterone compositions | Sep 04, 2036 | Antares Pharma Inc |
Xyosted (autoinjector) | US9744302 | Needle assisted jet injection device having reduced trigger force | Nov 19, 2035 | Antares Pharma Inc |
Xyosted (autoinjector) | US11191908 | Syringe shock absorber for use in an injection device | Oct 18, 2035 | Antares Pharma Inc |
Xyosted (autoinjector) | US11813435 | Needle assisted injection device having reduced trigger force | Feb 25, 2035 | Antares Pharma Inc |
Xyosted (autoinjector) | US10238662 | Needle assisted jet injection administration of testosterone compositions | Feb 19, 2035 | Antares Pharma Inc |
Xyosted (autoinjector) | US10912782 | Needle assisted injection administration of testosterone compositions | Feb 19, 2035 | Antares Pharma Inc |
Xyosted (autoinjector) | US11160751 | Hematocrit modulation through needle assisted jet injection of testosterone | Oct 07, 2034 | Antares Pharma Inc |
Xyosted (autoinjector) | US11771646 | Needle assisted jet injection administration of testosterone compositions | Apr 10, 2034 | Antares Pharma Inc |
Xyosted (autoinjector) | US10881798 | Needle assisted injection device having reduced trigger force | Feb 11, 2034 | Antares Pharma Inc |
Xyosted (autoinjector) | US10821072 | Needle assisted jet injection administration of testosterone compositions | Jun 04, 2033 | Antares Pharma Inc |
Xyosted (autoinjector) | US11844804 | Administration of testosterone compositions | Jun 04, 2033 | Antares Pharma Inc |
Xyosted (autoinjector) | US10357609 | Needle assisted jet injection device having reduced trigger force | Aug 21, 2031 | Antares Pharma Inc |
Xyosted (autoinjector) | US10905827 | Injection device with cammed ram assembly | Aug 21, 2031 | Antares Pharma Inc |
Xyosted (autoinjector) | US11446440 | Needle assisted injection device having reduced trigger force | Aug 21, 2031 | Antares Pharma Inc |
Xyosted (autoinjector) | US10279131 | Injection device with cammed RAM assembly | Jul 31, 2031 | Antares Pharma Inc |
Xyosted (autoinjector) | US11497753 | Hazardous agent injection system | Mar 19, 2030 | Antares Pharma Inc |
Xyosted (autoinjector) | US8021335 | Prefilled syringe jet injector | Oct 04, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US10478560 | Prefilled syringe injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US11446441 | Prefilled syringe injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US8562564 | Prefilled syringe jet injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US9180259 | Prefilled syringe jet injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US9533102 | Prefilled syringe jet injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | US9629959 | Prefilled syringe jet injector | Jan 24, 2026 | Antares Pharma Inc |
Xyosted (autoinjector) | USRE44846 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Antares Pharma Inc |
Xyosted (autoinjector) | USRE44847 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Antares Pharma Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Testosterone Enanthate's patents.
Latest Legal Activities on Testosterone Enanthate's Patents
Given below is the list recent legal activities going on the following patents of Testosterone Enanthate.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 4th Year, Large Entity | 01 Jul, 2024 | US10881798 |
Payment of Maintenance Fee, 4th Year, Large Entity | 01 May, 2024 | US10821072 |
Email Notification Critical
| 20 Dec, 2023 | US11844804 |
Recordation of Patent Grant Mailed Critical
| 19 Dec, 2023 | US11844804 |
Patent eGrant Notification | 19 Dec, 2023 | US11844804 |
Recordation of Patent eGrant | 19 Dec, 2023 | US11844804 |
Patent Issue Date Used in PTA Calculation Critical
| 19 Dec, 2023 | US11844804 |
Mail Patent eGrant Notification | 19 Dec, 2023 | US11844804 |
Email Notification Critical
| 30 Nov, 2023 | US11844804 |
Issue Notification Mailed Critical
| 29 Nov, 2023 | US11844804 |
Testosterone Enanthate's Family Patents
